SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-007401
Filing Date
2020-03-26
Accepted
2020-03-25 19:32:36
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO REGISTRATION STATEMENT ea119981-f1a2_therapixbio.htm F-1/A 1525057
2 FORM OF PLACEMENT AGENT AGREEMENT ea119981ex1-1_therapixbio.htm EX-1.1 95278
3 OPINION OF HORN & CO. - LAW OFFICES. ea119981ex5-1_therapixbio.htm EX-5.1 12045
4 OPINION OF ZYSMAN, AHARONI, GAYER AND SULLIVAN & WORCESTER LLP ea119981ex5-2_therapixbio.htm EX-5.2 14613
5 GRAPHIC image_001.jpg GRAPHIC 29351
6 GRAPHIC ex5-2_001.jpg GRAPHIC 19501
7 GRAPHIC ex5-2_002.jpg GRAPHIC 11581
8 GRAPHIC image_002.jpg GRAPHIC 5918
9 GRAPHIC image_003.jpg GRAPHIC 5912
  Complete submission text file 0001213900-20-007401.txt   1748256
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-236175 | Film No.: 20743610
SIC: 2834 Pharmaceutical Preparations